Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MCL1 | Q07820 | 4/20 | 0.71 |
| ▸ | CA1 | P00915 | 2/20 | 0.59 |
| ▸ | CA2 | P00918 | 2/20 | 0.59 |
| ▸ | PTGS2 | P35354 | 2/20 | 0.59 |
| ▸ | CA12 | O43570 | 1/20 | 0.59 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.59 |
| ▸ | CA7 | P43166 | 1/20 | 0.59 |
| ▸ | CA9 | Q16790 | 1/20 | 0.59 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.59 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.55 |
| ▸ | HPGD | P15428 | 3/20 | 0.55 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.55 |
| ▸ | MEN1 | O00255 | 2/20 | 0.55 |
| ▸ | KDR | P35968 | 2/20 | 0.55 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.55 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.55 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.55 |
| ▸ | TNF | P01375 | 1/20 | 0.55 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29623237 | 1.00 | MCL1 (0.71) | MCL1CA1CA2PTGS2CA12 | |
| SCHEMBL4625060 | 0.92 | MCL1 (0.62) | MCL1CA1CA2PTGS2CA12 | |
| SCHEMBL3196569 | 0.92 | MCL1 (0.62) | MCL1CA1CA2PTGS2CA12 | |
| SCHEMBL16203373 | 0.89 | MCL1 (0.64) | MCL1CA1CA2PTGS2CA12 | |
| SCHEMBL19914065 | 0.89 | CSNK2A1 (0.65) | MCL1CA1CA2PTGS2CA12 | |
| SCHEMBL739200 | 0.87 | MCL1 (0.71) | MCL1CA1CA2PTGS2CA12 | |
| SCHEMBL6715410 | 0.85 | MCL1 (0.69) | MCL1CA1CA2PTGS2CA12 | |
| SCHEMBL19914068 | 0.85 | MCL1 (0.71) | MCL1CA1CA2PTGS2CA12 | |
| SCHEMBL3187695 | 0.83 | MCL1 (1.00) | MCL1CA1CA2PTGS2CA12 | |
| SCHEMBL6400711 | 0.83 | MCL1 (0.67) | MCL1CA1CA2PTGS2CA12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 362 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024198980-A1 | POLYESTER COMPOSITION, PREPARATION METHOD THEREFOR, AND USE THEREOF | 金发科技股份有限公司 | 2024-10-03 | — | — | WO | claimed |
| US-12528983-B2 | Curable resin composition and display device | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2026-01-20 | — | — | US | disclosed |
| US-12504564-B2 | Layered body and display device | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2025-12-23 | — | — | US | disclosed |
| US-20250228063-A1 | COMPOSITION, FILM, AND DISPLAY DEVICE | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2025-07-10 | — | — | US | disclosed |
| US-20250215315-A1 | COMPOSITION, FILM, AND DISPLAY DEVICE | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2025-07-03 | — | — | US | disclosed |
| US-20250207026-A1 | COMPOSITION, FILM, AND DISPLAY DEVICE | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2025-06-26 | — | — | US | disclosed |
| EP-4559971-A1 | COMPOSITION, FILM, AND DISPLAY DEVICE | Sumitomo Chemical Company, Limited (JP) | 2025-05-28 | — | — | EP | disclosed |
| US-20250155803-A1 | CURABLE COMPOSITION, CURED FILM, AND DISPLAY DEVICE | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2025-05-15 | — | — | US | disclosed |
| EP-4502670-A1 | COMPOSITION, FILM, AND DISPLAY DEVICE | Sumitomo Chemical Company, Limited (JP) | 2025-02-05 | — | — | EP | disclosed |
| EP-4502074-A1 | COMPOSITION, FILM, AND DISPLAY DEVICE | Sumitomo Chemical Company, Limited (JP) | 2025-02-05 | — | — | EP | disclosed |
| EP-0600587-A1 | Photothermographic imaging materials and antifoggants therefor | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1994-06-08 | — | — | EP | disclosed |
| US-5258532-A | Hydroxyalkyl substituted o-hydroxynaphthoic acid derivatives; corrosion inhibitors | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1993-11-02 | — | — | US | disclosed |
| EP-0547231-A1 | PHOSPHOLIPASE A2 INHIBITOR | SHIONOGI & CO., LTD. (JP) | 1993-06-23 | — | — | EP | disclosed |
| EP-0537975-A1 | Positive-acting photothermographic materials | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1993-04-21 | — | — | EP | disclosed |
| US-5196297-A | Recording material and process of using | POLAROID CORPORATION (US) | 1993-03-23 | — | — | US | disclosed |
| EP-0490508-A2 | Corrosion inhibitor, preparation and use | ZENECA LIMITED (GB) | 1992-06-17 | — | — | EP | disclosed |
| EP-0250558-B1 | NOVEL COMPOUNDS AND NOVEL RECORDING MATERIAL USING THE SAME | POLAROID CORPORATION (US) | 1990-05-02 | — | — | EP | disclosed |
| EP-0250558-A1 | NOVEL COMPOUNDS AND NOVEL RECORDING MATERIAL USING THE SAME. | POLAROID CORP (US) | 1988-01-07 | — | — | EP | disclosed |
| US-4287366-A | BY OXIDATION OF THE CORRESPONDING SULFIDE OR SULFOXIDE WITH HYDROGEN PEROXIDE IN THE PRESENCE OF AN ALKALI METAL HYDROXIDE | MITSUI TOATSU CHEMICALS, INC. (JP) | 1981-09-01 | — | — | US | disclosed |
| US-4059580-A | Sulphonated polybenz-1,3-oxazin-2,4-diones | BAYER AKTIENGESELLSCHAFT (DT) | 1977-11-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12528983-B2 | Curable resin composition and display device | TIPRL, NLRP1, RCSD1 | MCL1 3239/4885CA1 3451/4885CA2 4040/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.